Skip to Main Content

Paper Details

Triaminopyrimidine is a fast-killing and long-acting antimalarial clinical candidate.
Nat Commun
44
2015
Author NameAffiliation
Vikas PatilAstraZeneca India Pvt. Ltd.
Amanda K LukensHarvard School of Public Health
Dyann F WirthHarvard School of Public Health
  • 1 - 3

Datasets

Release 1.2